Vanguard Capital Management’s MBX Biosciences MBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$83.9M Sell
1,430,897
-46,491
-3% -$2.91M ﹤0.01% 1626
2026
Q2
$81.6M Sell
1,477,388
-204
-0% -$7.12K ﹤0.01% 1668
2026
Q1
$44.1M Buy
+1,477,592
New +$50.2M ﹤0.01% 1920

Other funds holding MBX

Vanguard Capital Management's MBX Position: Q3 2026 in Review

Vanguard Capital Management reduced its MBX Biosciences (MBX) stake by 3.1% in Q3 2026, selling an estimated $2.91M and leaving 1,430,897 shares worth $83.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1626.

Vanguard Capital Management first reported a position in MBX in Q1 2026 and has held it in 3 quarters since. 190 funds tracked by Wall St. Rank hold MBX as of Q3 2026.

  • Vanguard Capital Management held 1,430,897 shares of MBX Biosciences worth $83.9M as of Q3 2026.
  • Vanguard Capital Management sold 46,491 MBX Biosciences shares in Q3 2026, an estimated $2.91M.
  • MBX Biosciences made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #1626 holding.
  • Vanguard Capital Management first reported a position in MBX Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 190 funds tracked by Wall St. Rank held MBX Biosciences as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.